AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
USE OF BISPHOSPHONATES IN PATIENTS WITH METASTATIC BONE-DISEASE
Authors: BERENSON JR LIPTON A
Citation: Jr. Berenson et A. Lipton, USE OF BISPHOSPHONATES IN PATIENTS WITH METASTATIC BONE-DISEASE, Oncology, 12(11), 1998, pp. 1573-1579
PHASE-II STUDY OF RECEPTOR-ENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185(HER2 NEU) MONOCLONAL-ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST-CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT/
Authors: PEGRAM MD LIPTON A HAYES DF WEBER BL BASELGA JM TRIPATHY D BALY D BAUGHMAN SA TWADDELL T GLASPY JA SLAMON DJ
Citation: Md. Pegram et al., PHASE-II STUDY OF RECEPTOR-ENHANCED CHEMOSENSITIVITY USING RECOMBINANT HUMANIZED ANTI-P185(HER2 NEU) MONOCLONAL-ANTIBODY PLUS CISPLATIN IN PATIENTS WITH HER2/NEU-OVEREXPRESSING METASTATIC BREAST-CANCER REFRACTORY TO CHEMOTHERAPY TREATMENT/, Journal of clinical oncology, 16(8), 1998, pp. 2659-2671
LONG-TERM PREVENTION OF SKELETAL COMPLICATIONS OF METASTATIC BREAST-CANCER WITH PAMIDRONATE
Authors: HORTOBAGYI GN THERIAULT RL LIPTON A PORTER L BLAYNEY D SINOFF C WHEELER H SIMEONE JF SEAMAN JJ KNIGHT RD HEFFERNAN M MELLARS K REITSMA DJ
Citation: Gn. Hortobagyi et al., LONG-TERM PREVENTION OF SKELETAL COMPLICATIONS OF METASTATIC BREAST-CANCER WITH PAMIDRONATE, Journal of clinical oncology, 16(6), 1998, pp. 2038-2044
LONG-TERM PAMIDRONATE TREATMENT OF ADVANCED MULTIPLE-MYELOMA PATIENTSREDUCES SKELETAL EVENTS
Authors: BERENSON JR LICHTENSTEIN A PORTER L DIMOPOULOS MA BORDONI R GEORGE S LIPTON A KELLER A BALLESTER O KOVACS M BLACKLOCK H BELL R SIMEONE JF REITSMA DJ HEFFERNAN M SEAMAN J KNIGHT RD
Citation: Jr. Berenson et al., LONG-TERM PAMIDRONATE TREATMENT OF ADVANCED MULTIPLE-MYELOMA PATIENTSREDUCES SKELETAL EVENTS, Journal of clinical oncology, 16(2), 1998, pp. 593-602
COLLAGEN CROSS-LINK EXCRETION DURING SPACE-FLIGHT AND BED REST
Authors: SMITH SM NILLEN JL LEBLANC A LIPTON A DEMERS LM LANE HW LEACH CS
Citation: Sm. Smith et al., COLLAGEN CROSS-LINK EXCRETION DURING SPACE-FLIGHT AND BED REST, The Journal of clinical endocrinology and metabolism, 83(10), 1998, pp. 3584-3591
MONITORING TREATMENT OF BONE METASTASES
Authors: CURLEY E DEMERS L COSTA L CHINCHILLI V SEAMAN J REITSMA D KNIGHT R LIPTON A
Citation: E. Curley et al., MONITORING TREATMENT OF BONE METASTASES, European journal of cancer, 33, 1997, pp. 660-660
PHASE-I STUDY COMBINING TUMOR-NECROSIS-FACTOR WITH INTERFERON-ALPHA AND INTERLEUKIN-2
Authors: ESKANDER ED HARVEY HA GIVANT E LIPTON A
Citation: Ed. Eskander et al., PHASE-I STUDY COMBINING TUMOR-NECROSIS-FACTOR WITH INTERFERON-ALPHA AND INTERLEUKIN-2, American journal of clinical oncology, 20(5), 1997, pp. 511-514
ENHANCED ANTIPROLIFERATIVE ACTIVITY OF THE COMBINATION OF TAMOXIFEN PLUS HER-2-NEU ANTIBODY
Authors: WITTERS LM KUMAR R CHINCHILLI VM LIPTON A
Citation: Lm. Witters et al., ENHANCED ANTIPROLIFERATIVE ACTIVITY OF THE COMBINATION OF TAMOXIFEN PLUS HER-2-NEU ANTIBODY, Breast cancer research and treatment, 42(1), 1997, pp. 1-5
PROSPECTIVE EVALUATION OF EXPANDABLE ESOPHAGEAL STENTS (EES) ON DYSPHAGIA, QUALITY-OF-LIFE (QLI), AND KARNOFSKY SCORES (KP)
Authors: KHANDELWAL M MUTH E GORDON R HARVEY H LIPTON A
Citation: M. Khandelwal et al., PROSPECTIVE EVALUATION OF EXPANDABLE ESOPHAGEAL STENTS (EES) ON DYSPHAGIA, QUALITY-OF-LIFE (QLI), AND KARNOFSKY SCORES (KP), Gastrointestinal endoscopy, 45(4), 1997, pp. 190-190
SKELETAL COMPLICATIONS OF MALIGNANCY - INTRODUCTION
Authors: LIPTON A MUNDY G SINGER FR
Citation: A. Lipton et al., SKELETAL COMPLICATIONS OF MALIGNANCY - INTRODUCTION, Cancer, 80(8), 1997, pp. 1527-1528
BISPHOSPHONATES AND BREAST-CARCINOMA
Authors: LIPTON A
Citation: A. Lipton, BISPHOSPHONATES AND BREAST-CARCINOMA, Cancer, 80(8), 1997, pp. 1668-1673
DETECTION OF MUTANT K-RAS DNA IN PLASMA OR SERUM OF PATIENTS WITH COLORECTAL-CANCER
Authors: KOPRESKI MS BENKO FA KWEE C LEITZEL KE ESKANDER E LIPTON A GOCKE CD
Citation: Ms. Kopreski et al., DETECTION OF MUTANT K-RAS DNA IN PLASMA OR SERUM OF PATIENTS WITH COLORECTAL-CANCER, British Journal of Cancer, 76(10), 1997, pp. 1293-1299
OVEREXPRESSION OF HER2 MODULATES BCL-2, BCL-X(L), AND TAMOXIFEN-INDUCED APOPTOSIS IN HUMAN MCF-7 BREAST-CANCER CELLS
Authors: KUMAR R MANDAL M LIPTON A HARVEY H THOMPSON CB
Citation: R. Kumar et al., OVEREXPRESSION OF HER2 MODULATES BCL-2, BCL-X(L), AND TAMOXIFEN-INDUCED APOPTOSIS IN HUMAN MCF-7 BREAST-CANCER CELLS, Clinical cancer research, 2(7), 1996, pp. 1215-1219
THE ROLE OF BISPHOSPHONATES IN THE TREATMENT OF BONE METASTASES - THEUS EXPERIENCE
Authors: HARVEY HA LIPTON A
Citation: Ha. Harvey et A. Lipton, THE ROLE OF BISPHOSPHONATES IN THE TREATMENT OF BONE METASTASES - THEUS EXPERIENCE, Supportive care in cancer, 4(3), 1996, pp. 213-217
NDF INDUCES EXPRESSION OF A NOVEL 46-KD PROTEIN IN ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER CELLS
Authors: KUMAR R MANDAL M RATZKIN BJ LIU NL LIPTON A
Citation: R. Kumar et al., NDF INDUCES EXPRESSION OF A NOVEL 46-KD PROTEIN IN ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER CELLS, Journal of cellular biochemistry, 62(1), 1996, pp. 102-112
THE IMPACT OF 2D VERSUS 3D QUANTITATION OF TUMOR BULK DETERMINATION ON CURRENT METHODS OF ASSESSING RESPONSE TO TREATMENT
Authors: HOPPER KD KASALES CJ EGGLI KD TENHAVE TR BELMAN NM POTOK PS VANSLYKE MA OLT GJ CLOSE P LIPTON A HARVEY HA HARTZEL JS
Citation: Kd. Hopper et al., THE IMPACT OF 2D VERSUS 3D QUANTITATION OF TUMOR BULK DETERMINATION ON CURRENT METHODS OF ASSESSING RESPONSE TO TREATMENT, Journal of computer assisted tomography, 20(6), 1996, pp. 930-937
PROTEIN-TYROSINE KINASE-ACTIVITY IN BREAST-CANCER AND ITS RELATION TOPROGNOSTIC INDICATORS
Authors: KOPRESKI MS WITTERS L BRENNAN WA BUCKWALTER EA CHINCHILLI VM DEMERS LM LIPTON A
Citation: Ms. Kopreski et al., PROTEIN-TYROSINE KINASE-ACTIVITY IN BREAST-CANCER AND ITS RELATION TOPROGNOSTIC INDICATORS, Anticancer research, 16(5B), 1996, pp. 3037-3041
GROWTH-INHIBITION OF BREAST-CANCER CELL-LINES BY COMBINATIONS OF ANTI-P185(HER2) MONOCLONAL-ANTIBODY AND CYTOKINES
Authors: KOPRESKI MS LIPTON A HARVEY HA KUMAR R
Citation: Ms. Kopreski et al., GROWTH-INHIBITION OF BREAST-CANCER CELL-LINES BY COMBINATIONS OF ANTI-P185(HER2) MONOCLONAL-ANTIBODY AND CYTOKINES, Anticancer research, 16(1), 1996, pp. 433-436
PHASE-I TRIAL OF RECOMBINANT PLATELET FACTOR-4 (RPF4) IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
Authors: BELMAN N BONNEM EM HARVEY HA LIPTON A
Citation: N. Belman et al., PHASE-I TRIAL OF RECOMBINANT PLATELET FACTOR-4 (RPF4) IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, Investigational new drugs, 14(4), 1996, pp. 387-389
EFFICACY OF PAMIDRONATE IN REDUCING SKELETAL COMPLICATIONS IN PATIENTS WITH BREAST-CANCER AND LYTIC BONE METASTASES
Authors: HORTOBAGYI GN THERIAULT RL PORTER L BLAYNEY D LIPTON A SINOFF C WHEELER H SIMEONE JF SEAMAN J KNIGHT RD HEFFERNAN M REITSMA DJ
Citation: Gn. Hortobagyi et al., EFFICACY OF PAMIDRONATE IN REDUCING SKELETAL COMPLICATIONS IN PATIENTS WITH BREAST-CANCER AND LYTIC BONE METASTASES, The New England journal of medicine, 335(24), 1996, pp. 1785-1791
EFFICACY OF PAMIDRONATE IN REDUCING SKELETAL EVENTS IN PATIENTS WITH ADVANCED MULTIPLE-MYELOMA
Authors: BERENSON JR LICHTENSTEIN A PORTER L DIMOPOULOS MA BORDONI R GEORGE S LIPTON A KELLER A BALLESTER O KOVACS MJ BLACKLOCK HA BELL R SIMEONE J REITSMA DJ HEFFERNAN M SEAMAN J KNIGHT RD
Citation: Jr. Berenson et al., EFFICACY OF PAMIDRONATE IN REDUCING SKELETAL EVENTS IN PATIENTS WITH ADVANCED MULTIPLE-MYELOMA, The New England journal of medicine, 334(8), 1996, pp. 488-493
FADROZOLE HYDROCHLORIDE IN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA
Authors: MILLER AA LIPTON A HENDERSON IC NAVARI R MULAGHA MT COOPER J
Citation: Aa. Miller et al., FADROZOLE HYDROCHLORIDE IN POSTMENOPAUSAL PATIENTS WITH METASTATIC BREAST-CARCINOMA, Cancer, 78(4), 1996, pp. 789-793
SERIAL SERUM C-ERBB-2 LEVELS IN PATIENTS WITH BREAST-CARCINOMA
Authors: VOLAS GH LEITZEL K TERAMOTO Y GROSSBERG H DEMERS L LIPTON A
Citation: Gh. Volas et al., SERIAL SERUM C-ERBB-2 LEVELS IN PATIENTS WITH BREAST-CARCINOMA, Cancer, 78(2), 1996, pp. 267-272
INTRODUCTION
Authors: LIPTON A DELMAS PD
Citation: A. Lipton et Pd. Delmas, INTRODUCTION, British journal of clinical practice, 1996, pp. 1-1
PAMIDRONATE (AREDIA(R))
Authors: LIPTON A
Citation: A. Lipton, PAMIDRONATE (AREDIA(R)), British journal of clinical practice, 1996, pp. 2-2
Risultati: 1-25 | 26-50